Oral GLP-1 pills seen softening blow to food company sales
Analysts argue pill formulations may blunt the appetite-suppression hit that injectables deliver to packaged food demand.
TR
By Tom Reyes · Markets Editor
Sep 17 12:05 ETSource: marketscreener.com
The wire
- 01Market commentary suggests GLP-1 pills could have a milder impact on food company sales than injections.
- 02Feeds an ongoing debate about obesity drugs' effect on consumer staples.
- 03Actual consumption data for oral GLP-1 users is still limited.
From the source
Read at news.google.comUse of GLP-1 Pills Seen to Ease Impact on Sales of Food Companies